Marissen, J.; Reichert, L.; Härtel, C.; Fortmann, M.I.; Faust, K.; Msanga, D.; Harder, J.; Zemlin, M.; Gomez de Agüero, M.; Masjosthusmann, K.;
et al. Antimicrobial Peptides (AMPs) and the Microbiome in Preterm Infants: Consequences and Opportunities for Future Therapeutics. Int. J. Mol. Sci. 2024, 25, 6684.
https://doi.org/10.3390/ijms25126684
AMA Style
Marissen J, Reichert L, Härtel C, Fortmann MI, Faust K, Msanga D, Harder J, Zemlin M, Gomez de Agüero M, Masjosthusmann K,
et al. Antimicrobial Peptides (AMPs) and the Microbiome in Preterm Infants: Consequences and Opportunities for Future Therapeutics. International Journal of Molecular Sciences. 2024; 25(12):6684.
https://doi.org/10.3390/ijms25126684
Chicago/Turabian Style
Marissen, Janina, Lilith Reichert, Christoph Härtel, Mats Ingmar Fortmann, Kirstin Faust, Delfina Msanga, Jürgen Harder, Michael Zemlin, Mercedes Gomez de Agüero, Katja Masjosthusmann,
and et al. 2024. "Antimicrobial Peptides (AMPs) and the Microbiome in Preterm Infants: Consequences and Opportunities for Future Therapeutics" International Journal of Molecular Sciences 25, no. 12: 6684.
https://doi.org/10.3390/ijms25126684
APA Style
Marissen, J., Reichert, L., Härtel, C., Fortmann, M. I., Faust, K., Msanga, D., Harder, J., Zemlin, M., Gomez de Agüero, M., Masjosthusmann, K., & Humberg, A.
(2024). Antimicrobial Peptides (AMPs) and the Microbiome in Preterm Infants: Consequences and Opportunities for Future Therapeutics. International Journal of Molecular Sciences, 25(12), 6684.
https://doi.org/10.3390/ijms25126684
